JMIR Cancer

Patient-centered innovations, education, and technology for cancer care, cancer survivorship, and cancer research.

Editor-in-Chief:

Naomi Cahill, PhD, RD, Editor-in-Chief; Scientific Editor at JMIR Publications, Canada


Impact Factor 3.3 CiteScore 4.1

JMIR Cancer (JC, ISSN: 2369-1999) is a peer-reviewed journal focusing on education, innovation and technology in cancer care, cancer survivorship and cancer research, and participatory and patient-centred approaches. This journal also includes research on non-Internet approaches to improve cancer care and cancer research.

We invite submissions of original research, viewpoints, reviews, tutorials, case studies, and non-conventional articles (e.g. open patient education material and software resources that are not yet evaluated but are free for others to use/implement). 

In our "Patients' Corner," we invite patients and survivors to submit short essays and viewpoints on all aspects of cancer. In particular, we are interested in suggestions on improving the health care system and suggestions for new technologies, applications and approaches (this section has no article processing fees).

In 2024, JMIR Cancer received a Journal Impact Factor™ of 3.3 (Source: Journal Citation Reports™ from Clarivate, 2024). JMIR Cancer is indexed in PubMed Central and PubMedScopusDOAJ, MEDLINE, and the Emerging Sources Citation Index (Clarivate). With a CiteScore of 4.1, JMIR Cancer is a Q2 journal in the field of Oncology, according to Scopus data.

Recent Articles

Article Thumbnail
Emotional, Social, Psychological Support for Cancer

Young adults (ages 18-39) with cancer face unique risks for negative psychosocial outcomes. These risks could be lessened with positive psychology interventions adapted for social media if intervention messages encourage intentions to do the activities and positive message reactions and young adults with cancer perceive few downsides.

|
Article Thumbnail
Innovations and Technology in Cancer Care

Strong evidence supports the benefits of exercise following both cardiovascular disease and cancer diagnosis. However, less than one third of Australians who are referred to exercise rehabilitation complete a program following a cardiac diagnosis. Technological advances make it increasingly possible to embed real-time supervision, tailored exercise prescription, behaviour change, and social support into home-based programs.

|
Article Thumbnail
Prostate Cancer

Despite advances in radiation techniques, radiation cystitis (RC) remains a significant cause of morbidity from pelvic radiotherapy, which may affect patients' quality of life (QoL). The pathophysiology of RC is not well understood, which limits the development of effective treatments.

|
Article Thumbnail
Innovations and Technology in Cancer Research

Chemotherapy can cause symptoms that impair quality of life and functioning. Remote monitoring of daily symptoms and activity during outpatient treatment may enable earlier detection and management of emerging toxicities but requires patients, including older and acutely ill patients, to engage with technology to report symptoms through smartphones and to charge and wear mobile devices.

|
Article Thumbnail
Breast Cancer

More than 85% of patients report heightened levels of anxiety following breast cancer diagnosis. Anxiety may become amplified during the early stages of breast cancer diagnosis when ambiguity is high. High levels of anxiety can negatively impact patients by reducing their ability to function physically, make decisions, and adhere to treatment plans, with all these elements combined serving to diminish the quality of life.

|
Article Thumbnail
Colon and Rectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the US. Early detection via routine CRC screening can significantly lower risks for CRC-specific morbidity and mortality. Public health initiatives between 2000-2015 nearly doubled CRC screening rates for some US adults. However, screening rates remain lowest for adults aged 45-49 years (20%), patients of safety-net healthcare facilities (42%), adults without insurance (44%) and other subgroups compared to national averages (72%). Given the evolving landscape of digital healthcare and trends in online health information seeking behaviors, leveraging online medical record (OMR) systems may be an underutilized resource to promote CRC screening utilization. Recognizing trends in OMR usage and patient demographics may enhance digital inclusion—a key social determinant of health—and support equitable online interventions aimed at boosting CRC screening across diverse populations.

|
Article Thumbnail
Cancer Survivorship

Young adult (YA) cancer survivors aged 18-39 frequently report unmet health information and peer support needs, as well as poor health-related quality of life (HRQOL). Our team has developed a supportive care intervention, titled TOGETHER-YA, to improve YA cancer survivors’ stress management skills. TOGETHER-YA is delivered via videoconference and has shown initial feasibility, acceptability, and promise for improving HRQOL among YA survivors.

|
Article Thumbnail
Breast Cancer

Whether COVID-19 is associated with a change in risk perception about other health conditions is unknown. Because COVID-19 occurred during a breast cancer study, we evaluated the effect of COVID-19 risk perception on women’s breast cancer risk perception.

|
Article Thumbnail
Breast Cancer

Breast cancer is the most common form of cancer in women. Adult weight gain and modifiable health behaviors, including smoking, alcohol intake, and lack of physical activity, are well-known risk factors. Most weight gain in women occurs between the ages of 18 and 35 years. Digital interventions have the potential to address logistical challenges that arise in reaching women in this age range. We designed a digital intervention targeting weight gain prevention and other modifiable health behaviors for young women at increased risk of breast cancer. Women aged 18 to 35 years were recruited to this single-arm intervention study over 2 months to test the acceptability and usability of the intervention, which comprised a group welcome event held via videoconferencing, app, and private Facebook group.

|
Article Thumbnail
Patient Education for Cancer

Music-based interventions (MBIs) are evidence-based, non-pharmacological treatments that include music therapy (MT), which is delivered by board-certified music therapists, as well as music services (MS), which are delivered by other healthcare professionals and volunteers. Despite MBI’s growing evidence base in cancer symptom management, it remains unclear how MBI-related information is presented to the public. Over 80% of people with cancer use the internet to find health-related information. In the United States, the National Cancer Institute (NCI) identifies certain cancer centers around the country as NCI-Designated Cancer Centers (CCs) or Comprehensive Cancer Centers (CCCs) based on their level of excellence in research. Because NCI-designated CCs and CCCs are considered the gold standard in cancer care, their websites are often viewed by the public as important sources of information.

|
Article Thumbnail
Cancer Epidemiology, Cancer Surveillance and Infodemiology

Tobacco use has been identified as a risk factor for oral cancer worldwide. However, relative oral cancer incidence among adults who smoke cigarettes, use smokeless tobacco products (ST), have transitioned from cigarettes to ST, quit both cigarettes and/or ST (“quitters”), or never used tobacco has not been well studied.

|

We are working in partnership with